[TRVI] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[TRVI] Trevi Therapeutics, Inc.
Announcement Date
20-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -1.60%
YoY- -42.10%
Quarter Report
TRVI's Result
TRVI's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 176 0 0 0 -
PBT -13,273 -12,360 -10,910 -7,803 -7,711 -7,175 -6,408 62.27%
Tax -31 -8 -8 18 -13 -30 -7 168.94%
NP -13,242 -12,352 -10,902 -7,821 -7,698 -7,145 -6,401 62.14%
Tax Rate - - - - - - - -
Total Cost 13,242 12,352 10,902 7,997 7,698 7,145 6,401 62.14%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -4,443.75 0.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.13 -0.12 -0.11 -0.08 -0.08 -0.07 -0.06 67.20%
EPS Diluted -0.13 -0.12 -0.11 -0.08 -0.08 -0.07 -0.06 67.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.